drugset / Trial / NCT02749656
Efficacy and Safety of 0.25% Desoximetasone Cream (Topoxy®) in the Treatment of Scalp Psoriasis
Phase 3
Unknown
105 enrolled
Siriraj Hospital
SPS MEDICAL CO.,LTD. · collabSiriraj clinical research center · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate efficacy and safety of 0.25% Desoximetasone cream (Topoxy®) compare with 0.25% Desoximetasone cream (Topicorte®) in the treatment of scalp psoriasis.
Timeline
- Start
- 2016-01-01
- Primary completion
- 2018-01
- Completion
- 2018-12
Publications
- Background Kircik L, Lebwohl MG, Del Rosso JQ, Bagel J, Stein Gold L, Weiss JS. Clinical study results of desoximetasone spray, 0.25% in moderate to severe plaque psoriasis. J Drugs Dermatol. 2013 Dec;12(12):1404-10.
- Background Kuokkanen K. Comparison of 0.25% desoxymethasone ointment with 0.05% fluocinonide ointment in psoriasis. Curr Med Res Opin. 1976-1977;4(10):703-5. doi: 10.1185/03007997609112005.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Desoximetasone | Small molecule | 0.25 % | Topical |